|
TVIS44042816
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
25109809 |
25109809 |
p11.21 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042817
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
24166021 |
24166021 |
p11.21 |
LINC01721 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042818
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
23906716 |
23906716 |
p11.21 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042819
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
23607261 |
23607261 |
p11.21 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042820
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
2284196 |
2284196 |
p13 |
ENSG00000286022 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042821
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
21551505 |
21551505 |
p11.22 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042822
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
21048230 |
21048230 |
p11.23 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042823
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
21048222 |
21048222 |
p11.23 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042824
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
21048210 |
21048210 |
p11.23 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042825
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
21048179 |
21048179 |
p11.23 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |